Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
|Articles|January 2, 2015
- Pharmaceutical Technology-01-02-2015
- Volume 39
- Issue 1
Ross Charging Hopper Increases Efficiency
Ross’ high-efficiency charging hopper for High Shear Mixers with Solids/Liquid Injection Manifold (SLIM) Technology is designed for high-speed powder injection into liquids and eliminates the need for eductors or pumps. The design improves the rate of feed delivery at a steady pace and prevents the bridging of bulk solids, which include: fumed silica, CMC, guar gum, carbon black, carrageenan, xanthan gum, talc, alginates, pectin, titanium dioxide, calcium carbonate, starch, clays, alumina, carbomers, sugar, salts, and dye powders.
The 30HP SLIM mixer is equipped with three level transmitters and a solenoid-operated multi-position modulating valve to maintain a liquid flow rate within 80% to 100% of the 500 gpm design flow rate. All contact parts are made of stainless steel 316 polished to 150-grit (32 Ra) finish.
Ross, Charles & Son Company
Article DetailsPharmaceutical Technology
Vol. No. 1
Page: 14
Articles in this issue
almost 12 years ago
Value-Based Healthcare in the: United Kingdomalmost 12 years ago
Mitigating Risk for Single-Use Assemblies in Sterile Fillingalmost 12 years ago
Building a Barrier in Solid-Dosage Drug Packagingalmost 12 years ago
Using Tocophersolan for Drug Deliveryalmost 12 years ago
Industry Expert Q&A with Fred Miesowiczalmost 12 years ago
Innovative Excipients in Solid-Dosage Manufacturingalmost 12 years ago
Great Expectations from New European Commissionalmost 12 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsalmost 12 years ago
Standards Organizations Updatealmost 12 years ago
Politics and Patients to Shape Pharma in 2015Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.